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Abstract
Background: Burkholderia pseudomallei is the causative agent of melioidosis, an emerging bacterial infectious
disease in tropical and subtropical areas. We recently showed that NADPH oxidase but not nitric oxide (NO)
contributes to resistance in innately resistant C57BL/6 mice in a B. pseudomallei respiratory infection model.
However, the function of NO for resistance was shown to differ among distinct strains of mice and proved also to
be stage dependent in various infection models. The present study therefore aimed to examine the role of NO in a
systemic infection model of melioidosis and to test whether the function of NO differs among innately resistant
C57BL/6 and susceptible BALB/c mice after B. pseudomallei infection.
Results: C57BL/6 iNOS-/- mice that were intravenously infected with B. pseudomallei survived several weeks,
whereas most of the wild type animals succumbed during this period. The bacterial burden in liver and spleen was
significantly higher in wild type animals compared to iNOS-/- mice 13 days after challenge. In contrast, BALB/c
mice that were treated with amminoguanidine to inhibit NO expression in vivo showed significantly enhanced
mortality rates and higher bacterial loads in liver and spleen compared to control animals. The bactericidal function
of IFN-g stimulated C57BL/6 iNOS-/- macrophages were not altered after B. pseudomallei infection, but BALB/c
macrophages exhibited reduced killing activity against the pathogen when NO was inhibited.
Conclusion: Our present data indicate a dual role of NO among resistant and susceptible mouse strains after
B. pseudomallei infection. NO mediated mechanisms are an essential component to control the infection in
susceptible BALB/c mice. In contrast, NO production in B. pseudomallei infected C57BL/6 mice rather harmed the
host likely due to its detrimental effects.
Background
Nitric oxide (NO) is a free radical molecule that can be
expressed by several cell types including fibroblasts,
hepatocytes, and phagocytes via nitric oxide synthases.
NO exhibits many pleiotropic functions, among these
microbicidal activity, and a role in immune regulation
are of special interest after infection with parasites,
bacteria or viruses. Release of NO can restrict the
growth of several pathogens in the host [1-5], but is also
known to cause nonspecific damage in host cells
that can lead to an exacerbation after infection [2,6].
A rather protective or damaging function for NO was
also described to be dependent on the stage of infection
or the background mouse strain in several murine infec-
tion models [4,6-9].
Burkholderia pseudomallei comprises a facultative
intracellular gram-negative rod and is the causative
agent of melioidosis, an emerging infectious disease of
humans and animals in certain areas of the tropics and
subtropics [10]. The infection is thought to be acquired
by inoculation into minor cuts,a b r a s i o n s ,o ri n h a l a t i o n
after contact with contaminated water or soil [11]. Clini-
cal manifestations are variable, ranging from inapparent
to localized chronic infections and fulminant acute sep-
ticemias with high mortality rate [12].
Several reports could show that the inbred mouse
strains C57BL/6 and BALB/c differed in their outcome
after B. pseudomallei challenge [13-15]. Irrespective
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tion, the LD50 of C57BL/6 mice was 100-fold higher
compared to BALB/c mice [13,14]. In addition, BALB/c
mice exhibited significantly higher bacterial loads in
liver and spleen already 12 h after intravenous infection
compared to C57BL/6 mice [13]. Thus, C57BL/6 mice
are considered to represent a relatively resistant mouse
strain in murine melioidosis, whereas BALB/c mice are
highly susceptible. We previously have shown that
macrophages were essential for resistance in both
BALB/c and C57BL/6 mice to control B. pseudomallei
infection [16]. By further investigating bactericidal effec-
tor molecules of macrophages, we could not find any
protective function for NO in resistance of C57BL/6
mice in a respiratory infection model or in controlling
intracellular B. pseudomallei in macrophages [16]. How-
ever, we could neither exclude whether NO might play
a role when bacteria were administered systemically, or
a protective function in innate susceptible BALB/c mice.
T h ep r e s e n ts t u d ya i m e dt of u r t h e re l u c i d a t et h er o l e
of NO for resistance against B. pseudomallei in a sys-
temic model of murine melioidosis. We compared the
outcome of susceptible BALB/c and relatively resistant
C57BL/6 mice lacking NO expression after intravenous
infection with B. pseudomallei. To examine the impact
of NO in controlling intracellular B. pseudomallei
growth in macrophages, we analyzed the intracellular
survival kinetics in primary bone marrow derived
macrophages from BALB/c and C57BL/6 mice that lack
NO release.
Results
Lack of iNOS renders C57BL/6 mice more resistant
against systemic B. pseudomallei infection
Nitric oxide (NO) and reactive oxygen intermediates are
downstream effector molecules of IFN-g that vary in
their importance for resistance among a wide array of
pathogens in murine infection models [3-5]. Whereas
NADPH oxidase was crucial for resistance in C57BL/6
mice, we did not find any role for NO to control
B. pseudomallei infection in the resistant mouse strain
in a respiratory infection model. Moreover, C57BL/6
wild type mice even showed an increased bacterial bur-
den compared to iNOS
-/- mice [16]. To test whether
NO might have a protective role after systemic infection
with B. pseudomallei, we investigated iNOS
-/- mice in an
intravenous infection model of melioidosis. As demon-
strated in Figure 1A, C57BL/6 wild type animals that
received a moderate B. pseudomallei infection dose, died
within approximately one month after challenge whereas
all iNOS-/- animals survived the observed period. Signif-
icant differences in the bacterial load of liver and spleen
were observed about 13 days after challenge (Figure 1B).
These data indicate that, in accordance with our results
obtained in the acute respiratory infection model, NO
mediated functions seem to have rather detrimental
than beneficial effects in resistant C57BL/6 mice after
intravenous B. pseudomallei challenge.
NO contributes to resistance against B. pseudomallei
infection in BALB/c mice
In a murine Toxoplasma gondii infection model the
contribution of NO for resistance was shown to differ
among different strains of mice [7,9]. Since genetically
iNOS deficient mice on BALB/c background are at pre-
sent not available, aminoguanidine (AG) treatment was
used to selectively inhibit NO release in BALB/c mice in
vivo, an approach that has been successfully established
in several murine infection models [4,7]. To show the
effectiveness of AG treatment in vivo, serum of BALB/c
mice that were intravenously infected with ~ 5 × 10
4
CFU B. pseudomallei was taken 24 h after infection.
The concentration of nitrite in the serum of sham trea-
ted mice was 74.3 ± 7.2, and 38.4 ± 3.2 in AG treated
animals (n = 5, p = 0.0018). Thus, release of NO in vivo
was significantly reduced under AG treatment and
B. pseudomallei infection. To examine the role of
N Of o rr e s i s t a n c ei ns u s c e p t i b l eB A L B / cm i c ea f t e r
B. pseudomallei infection, sham-treated and AG treated
mice were intravenously infected with B. pseudomallei.
Our data demonstrate that inhibition of NO significantly
impaired survival rate of BALB/c mice compared to
control animals (Figure 2A). By comparing the bacterial
load of internal organs we found significantly enhanced
bacterial burden within 24 h after infection in the
liver of AG treated animals compared to control mice
(Figure 2B). Four days after infection bacterial load was
higher in both spleen and liver in NO depleted mice
(Figure 2B). These data suggest that NO contributes to
resistance against B. pseudomallei challenge in the sus-
ceptible mouse strain BALB/c.
Macrophages from C57BL/6 and BALB/c mice lacking NO
differ in their ability to control intracellular growth of B.
pseudomallei
In our previous study we showed that primary bone
marrow derived macrophages obtained from resistant
C57BL/6 mice exhibited a better ability to eliminate
intracellular B. pseudomallei compared to macrophages
from susceptible BALB/c mice [16]. This phenomenon
became especially apparent after IFN-g stimulation, sug-
gesting that IFN-g mediated effector functions are cru-
cial for determining the distinct bactericidal activity of
these cells. Since we found that NO differs in its role to
control B. pseudomallei infection among resistant and
susceptible mice in vivo, we were interested whether
NO might also differ in its contribution to eliminate
intracellular B. pseudomallei in macrophages from
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Page 2 of 7C57BL/6 and BALB/c mice. We therefore examined
the intracellular survival kinetics of intracellular
B. pseudomallei in iNOS deficient C57BL/6 macro-
phages. We could not detect any role for NO to control
intracellular B. pseudomallei growth in macrophages
from relatively resistant C57BL/6 mice, even by extend-
ing the incubation time up to four days (Figure 3A). To
test the role of NO in macrophages from more suscepti-
ble BALB/c mice, macrophages were treated with AG in
vitro to inhibit NO release. As shown in Figure 3B, AG
treatment could reliably inhibit NO release from
B. pseudomallei infected macrophages. In contrast to the
results obtained in NO deficient C57BL/6 macrophages,
BALB/c macrophages in that NO was inhibited could not
reduce the number of intracellular B. pseudomallei
within 24 h and 48 h after infection compared to
untreated macrophages (Figure 3C). These results are
consistent with our data obtained in vivo, in that NO has
beneficial and bactericidal effects in BALB/c mice, under-
lining the importance for NO in the susceptible mouse
strain.
Discussion
The IFN-g effector molecule NO is known to contribute
to resistance against a variety of pathogens such as
Mycobacterium tuberculosis, Salmonella, Chlamydia,
Toxoplasma gondii, and others [1-5]. Our present data
indicate that NO seems to have a two-sided role in
murine B. pseudomallei infection, dependent on the
background mouse strain. In a respiratory infection
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Figure 1 Detrimental role of NO in innate resistant C57BL/6 mice after B. pseudomallei challenge. (A) Survival curve of C57BL/6 wild type
and iNOS-/- mice (n = 10) after intravenous (i.v.) infection with 0.2 - 1 × 10
5 CFU B. pseudomallei. Pooled data from two experiments are shown.
(B) Bacterial burden in liver and spleen of C57BL/6 wild type and iNOS-/- mice 2 d and 13 d after i.v. infection with ~ 3 × 10
4 CFU B.
pseudomallei. Pooled data from two independent experiments are shown. Each dot represents the bacterial count of the respective organ of a
single animal. The line represents the median of each group. Statistical analyses were performed by using the Mann-Whitney test.
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not play a role for resistance in innate relatively resis-
tant C57BL/6 mice, but iNOS-/- mice tend to be more
protected from infection [16]. Similar observations
were obtained in mice that were challenged intrave-
nously with B. pseudomallei in the present study. Simi-
lar phenomena have also been observed in a murine
Toxoplasma gondii and HSV-1 infection model [6,17]
where inhibition of NO led to prolonged survival of
infected mice. Since at the same time lack of NO
expression was associated with an increased load of
the respective pathogen in tissues, it was suggested
that NO has both, a microbicidal function as well as a
detrimental role that led to immunopathologic changes
and finally caused death [6,17]. However, the bacterial
load in internal organs of C57BL/6 iNOS-/- mice was
neither enhanced in a respiratory nor in an intrave-
nous B. pseudomallei infection model. In contrast, the
number of live bacteria was significantly lower com-
pared to control animals ([16] and present study). This
is in clear contrast to results obtained in Toxoplasma
and HSV-1 infection studies where NO - despite its
damaging effect - had a role in restricting growth of
the pathogens [6,17]. However, after infection with
B. pseudomallei, dispensable NO production in wild
type mice is likely to cause damage to host cells. This
might eventually led to a reduced ability to control
bacterial growth and finally contribute for a higher
mortality compared to animals that lack NO expres-
sion. Thus, in contrast to other murine infection
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Figure 2 Protective role of NO for resistance in innate susceptible BALB/c mice after B. pseudomallei challenge. (A) Survival curve of AG-
treated and control BALB/c mice (n = 10) after i.v. infection with ~300 CFU B. pseudomallei. Pooled data from two independent experiments are
shown. (B) Bacterial burden in liver and spleen of sham treated and AG treated BALB/c mice 1 d and 4 d after i.v. infection with ~ 400 CFU B.
pseudomallei, respectively. Data from single experiments are shown. Each dot represents the bacterial count of the respective organ of a single
animal. The line represents the median of each group. Statistical analyses were performed by using the Mann-Whitney test.
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exhibit detectable killing activity against pathogens
[6,7], we did not found NO to contribute for the elimi-
nation or even reduction of the bacterial load after
B. pseudomallei infection in innate relatively resistant
C57BL/6 mice.
In contrast to the phenotype observed in C57BL/6
mice, we found NO to contribute to in vivo resistance
in innate susceptible BALB/c mice. Also the in vitro kill-
ing activities of primary BALB/c macrophages were sig-
nificantly decreased when NO was inhibited. Since our
previous finding revealed that macrophages are abso-
lutely essential for resistance in both susceptible and
resistant mice [16], we assume that NO-mediated killing
activity of macrophages is likely to contribute to resis-
tance in BALB/c mice. This assumption is supported by
our finding that enhanced mortality was associated with
enhanced bacterial burden in spleens and livers of AG
treated BALB/c mice. The fact that NO was dispensable
for controlling B. pseudomallei growth in C57BL/6 mice
indicates that IFN-g dependent but NO-independent
bactericidal mechanisms are crucial for resistance in this
mouse strain. In contrast, bactericidal mechanisms that
are present in C57BL/6 mice obviously lack to work effi-
ciently in BALB/c mice. Thus, beneficial effects of NO
seem to outweigh damaging effects in susceptible mice
after B. pseudomallei challenge. Differences in the role
of NO for resistance in susceptible and resistant mice
have so far been described in a Toxoplasma gondii
infection model, where - similar to our findings - NO
contributed to resistance in innate susceptible but not
resistant mice [7,9].
Conclusions
The function of NO in resistance against a pathogen can
differ among susceptible and resistant mouse strains.
We here report that NO has rather damaging effects in
innate resistant C57BL/6 mice in a murine model of
melioidosis and did not play any role in the killing activ-
ity of C57BL/6 macrophages. In contrast, NO contribu-
ted to full resistance in innate susceptible BALB/c mice
and was also involved in restricting the intracellular
growth of macrophages from susceptible mice. The
ambiguous role for NO to either protect or affect the
host is likely to serve as one component that determines
susceptibility against B. pseudomallei infection.
Methods
Bacteria
Burkholderia pseudomallei strain E8 was used through-
out the study [16]. Bacteria were grown on Columbia
agar at 37°C for 24 h. Colonies were harvested using LB
broth containing 20% glycerol and frozen in 50 μla l i -
quots at -70°C.
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Figure 3 Differential function for NO in macrophages from
C57BL/6 and BALB/c mice to control B. pseudomallei growth.
(A) Intracellular survival of B. pseudomallei in IFN-g stimulated BMM
from C57BL/6 wild type and iNOS-/- mice (MOI ~ 50:1). One
representative experiment out of five independent experiments is
shown. (B) NO production of BALB/c macrophages without and
with AG treatment after B. pseudomallei infection (MOI ~ 65).
(C) Intracellular survival of B. pseudomallei in IFN-g stimulated BALB/c
BMM (MOI ~ 65) with and without AG treatment. One
representative experiment out of three independent experiments is
shown. Values are the means ± standard deviations from triplicate
determinations. Statistical analysis was performed using the
Student’s t-test.
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Female BALB/c mice were obtained from Charles River
(Wiga Sulzfeld, Germany). iNOS-/- and respective
C57BL/6J control mice were obtained from The Jackson
Laboratory (Bar Harbor, Maine). Animals were provided
with food and water ad libitum. Generally, naturally
occurring death of infected animals was documented as
survival end points. However, approx. 20 percent of
mice that were observed to be severely ill were eutha-
nized. All mouse experiments were performed in full
compliance with the relevant laws and approved by the
Landesamt für Landwirtschaft, Lebensmittelsicherheit
und Fischerei, Western Pommerania, Germany (Az:
LALLF M-V/TSD/7221.3-1.1-044/05).
Infection of mice and determination of organ bacterial
burden
Frozen bacteria were thawed from the stock, plated on
Colombia Agar, and grown overnight. Prior to infection,
bacteria were harvested from Colombia Agar and
diluted in phosphate buffered saline (PBS) to the appro-
priate concentration. For intravenous (i.v.) infection, a
bacterial suspension of 200 μl was injected into the lat-
eral tail vein. The mortality of the animals was moni-
tored daily. To enumerate bacteria in internal organs,
organs were aseptically removed and homogenized in
0.5 to 1 ml sterile PBS containing 0.5% Tergitol and 1%
bovine serum albumin. Organ suspensions were plated
on Ashdown agar and number of CFU was determined.
NO inhibition in vivo
To selectively inhibit NO production in vivo, we treated
mice with aminoguanidin (AG) as reported by others
[18]. Mice continuously received AG via drinking water
(2% w/v) at least six days prior to and during infection
and were additionally treated i.p. 6 h prior and 18 h
after B. pseudomallei challenge with AG (1.5 mg AG
per animal in 200 μlP B S ) .C o n t r o la n i m a l sr e c e i v e d
sham injections with PBS.
Culture and infection of bone marrow derived
macrophages (BMM)
Murine bone marrow derived macrophages (BMM) were
generated under serum-free conditions from BALB/c
mice as previously described [19]. Briefly, tibias and
femurs were aseptically removed, and bone marrow cells
were flushed with sterile PBS and then centrifuged at
150 × g for 10 min. Cells were resuspended in RPMI
medium containing 5% Panexin BMM (PAN Biotech,
Aidenbach, Germany), 2 ng/ml of recombinant murine
granulocyte-macrophage colony-stimulating factor (PAN
Biotech), and 50 μM mercaptoethanol and cultivated for
at least 10 days at 37°C and 5% CO2. Twenty-four hours
prior to infection experiments, cells were seeded in 48 well
plates (1.5 × 10
5 cells per well) and infected with B. pseu-
domallei at a MOI as indicated for each experiment for
30 min. Cells were then washed twice with PBS and med-
ium containing 100 μg/ml kanamycin was added to each
well. At the indicated time points (time zero was taken 20
min after incubation under antibiotic-containing medium)
the number of intracellular colony forming units (CFU)
was determined [19]. IFN-g stimulation was performed
using 100 U/ml IFN-g. For in vitro NO inhibition of
BALB/c BMM, cells were treated by adding 2 mM AG
into the medium 16-20 h prior to infection, during the
3 0m i ni n f e c t i o nt i m ew i t hB. pseudomallei and subse-
quent incubation under kanamycin-containing medium.
NO-Assay
Measurement of NO was performed as recently
d e s c r i b e d[ 1 9 ] .T om e a s u r eN Oi nc e l lc u l t u r es u p e r -
nantant, cells were seeded in 96 well plates 24 h prior
to infection and IFN-g at a concentration of 100 ng/ml
was added. Cells were infected with B. pseudomallei und
incubated under kanamycin-containing medium as
described above. At indicated time point cell culture
supernatant was collected and NO production was
determined by the Griess reagent system. To determine
NO concentration in the serum, 100 μls e r u ms a m p l e s
were rigorously mixed with 100 μl acetonitril and centri-
fuged for 10 minutes at 10 000 × g to remove serum
proteins. Serum supernatant was taken and measured as
described above.
Statistical analysis
Kaplan-Meier survival curves and the log rank test were
used to compare the mortality of different groups of
mice. To compare statistical significances of bacterial
loads in internal organs or macrophages, either the Stu-
dent’s t-test or Mann-Whitney test was used as indicated
for each experiment. Statistical significances were deter-
mined as follows: *p = 0.1, ** p = 0.01, *** p = 0.001.
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